Publication date: May 29, 2025
Background: Nursing leadership is associated with a host of benefits for patient outcomes and health services. Pressures relating to the COVID-19 pandemic saw many relatively inexperienced nurses thrust into leadership roles, often with little notice. In response to this situation, The Tasmanian Health Service-Hospitals South created the Leadership Excellence in Practice Program (L-EPP) as a way of developing the leadership skills of its nurses and midwives. This study aimed to describe the development of the L-EPP and to evaluate it from the perspective of its participants and their peers. Methods: A longitudinal mixed-methods study was conducted using data from the first two offerings of the L-EPP. The L-EPP employs a blended learning model comprised of e-learning, work-integrated learning and face-to-face workshops. Surveys targeting the participants’ leadership abilities were completed at numerous time points by participants themselves, their peers, and their managers. Results: A total of 57 participants completed the program. Workshop surveys indicated that these sessions were generally well-received by participants. Significant improvements were observed in several domains of leadership, from the perspective of the participants themselves and their peers and managers. Conclusions: The program was well-received by its participants, and would serve as a useful template for other organisations seeking to build the leadership capacity of their nurses and midwives. This may be particularly useful to organisations seeking to upskill their existing staff and prevent further attrition of nurses and midwives in the wake of the pandemic.
Open Access PDF
Concepts | Keywords |
---|---|
Basel | attrition |
Hospitals | capacity building |
Learning | leadership |
Midwives | professional development |
Pandemic | succession planning |
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | host |
disease | MESH | COVID-19 pandemic |
drug | DRUGBANK | Etoperidone |
disease | IDO | process |
disease | IDO | site |
disease | MESH | burnout |
disease | IDO | quality |
drug | DRUGBANK | Methionine |
drug | DRUGBANK | Huperzine B |
drug | DRUGBANK | Ranitidine |